Publication: Extramedullary relapsed multiple myeloma treatment with 177Lu-Labeled CXCR4 endoradiotherapy and dosimetric results
dc.contributor.coauthor | Uçar, Burcu | |
dc.contributor.coauthor | Wester, Hans-Juergen | |
dc.contributor.department | School of Medicine | |
dc.contributor.kuauthor | Demirkol, Mehmet Onur | |
dc.contributor.kuauthor | Ferhanoğlu, Ahmet Burhan | |
dc.contributor.kuauthor | Özkan, Ahu | |
dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
dc.date.accessioned | 2024-11-09T23:06:38Z | |
dc.date.issued | 2021 | |
dc.description.abstract | We created our first national clinical protocol of Lu-177-CXCR4 therapy for patient who have failed to respond to current therapy options. We also calculated the kidney, liver, and tumor dosimetry. The kidney's mean absorbed dose was calculated to be 0.45 Gy/GBq, the calculated radiation absorbed dose of the liver was 0.63 Gy/GBq, and the radiation absorbed doses of the tumors vary between 9.2 and 82 Gy/GBq. Lu-177-CXCR4 therapy produced a promising clinical response in our patient in acceptable radiation dose limits as a treatment option in heavily pretreated patients with advanced multiple myeloma. | |
dc.description.indexedby | WOS | |
dc.description.indexedby | Scopus | |
dc.description.issue | 8 | |
dc.description.openaccess | NO | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.sponsorship | Koc University Hospital This work was supported by the İstanbul American Hospital and Koc University Hospital. | |
dc.description.volume | 46 | |
dc.identifier.doi | 10.1097/RLU.0000000000003705 | |
dc.identifier.eissn | 1536-0229 | |
dc.identifier.issn | 0363-9762 | |
dc.identifier.quartile | Q1 | |
dc.identifier.scopus | 2-s2.0-85110666378 | |
dc.identifier.uri | https://doi.org/10.1097/RLU.0000000000003705 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/9006 | |
dc.identifier.wos | 669618500019 | |
dc.keywords | Multiple myeloma | |
dc.keywords | CXCR4 | |
dc.keywords | Endoradiotherapy | |
dc.keywords | Pentixather | |
dc.keywords | Dosimetry | |
dc.language.iso | eng | |
dc.publisher | Lippincott Williams & Wilkins | |
dc.relation.ispartof | Clinical Nuclear Medicine | |
dc.subject | Radiology | |
dc.subject | Nuclear medicine | |
dc.subject | Medical imaging | |
dc.title | Extramedullary relapsed multiple myeloma treatment with 177Lu-Labeled CXCR4 endoradiotherapy and dosimetric results | |
dc.type | Other | |
dc.type.other | Editorial material | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Demirkol, Mehmet Onur | |
local.contributor.kuauthor | Özkan, Ahu | |
local.contributor.kuauthor | Ferhanoğlu, Ahmet Burhan | |
local.publication.orgunit1 | SCHOOL OF MEDICINE | |
local.publication.orgunit2 | School of Medicine | |
relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |